PMC:7784786 / 10222-11788
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
381 | 516-524 | Gene | denotes | IFN α-2b | Gene:3440 |
382 | 1122-1126 | Gene | denotes | IL-6 | Gene:3569 |
383 | 1199-1203 | Gene | denotes | IL-6 | Gene:3569 |
384 | 1375-1379 | Gene | denotes | IL-1 | Gene:3553 |
385 | 1384-1389 | Gene | denotes | TNF-α | Gene:7124 |
386 | 1471-1474 | Gene | denotes | AST | Gene:26503 |
387 | 184-191 | Species | denotes | Patient | Tax:9606 |
388 | 611-618 | Species | denotes | Patient | Tax:9606 |
389 | 1046-1053 | Species | denotes | Patient | Tax:9606 |
390 | 1345-1352 | Species | denotes | patient | Tax:9606 |
391 | 421-427 | Chemical | denotes | Oxygen | MESH:D010100 |
392 | 466-477 | Chemical | denotes | ceftriaxone | MESH:D002443 |
393 | 479-498 | Chemical | denotes | lopinavir–ritonavir | MESH:C558899 |
394 | 500-511 | Chemical | denotes | chloroquine | MESH:D002738 |
395 | 727-737 | Chemical | denotes | itolizumab | MESH:C000597346 |
396 | 1307-1317 | Chemical | denotes | itolizumab | MESH:C000597346 |
397 | 41-49 | Disease | denotes | COVID-19 | MESH:C000657245 |
398 | 218-230 | Disease | denotes | hypertension | MESH:D006973 |
399 | 232-249 | Disease | denotes | diabetes mellitus | MESH:D003920 |
400 | 251-259 | Disease | denotes | glaucoma | MESH:D005901 |
401 | 310-315 | Disease | denotes | cough | MESH:D003371 |
402 | 330-338 | Disease | denotes | diarrhea | MESH:D003967 |
403 | 357-372 | Disease | denotes | viral pneumonia | |
404 | 376-384 | Disease | denotes | COVID-19 | MESH:C000657245 |
405 | 914-934 | Disease | denotes | respiratory distress | MESH:D012128 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T43 | 218-230 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T44 | 232-249 | Phenotype | denotes | diabetes mellitus | http://purl.obolibrary.org/obo/HP_0000819 |
T45 | 251-259 | Phenotype | denotes | glaucoma | http://purl.obolibrary.org/obo/HP_0000501 |
T46 | 310-315 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
T47 | 317-325 | Phenotype | denotes | wheezing | http://purl.obolibrary.org/obo/HP_0030828 |
T48 | 330-338 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
T49 | 363-372 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T50 | 914-934 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T92 | 0-10 | Sentence | denotes | Patient 3: |
T93 | 11-119 | Sentence | denotes | An 81-year old female, who is COVID-19 positive contact was not identified at the moment of hospitalization. |
T94 | 120-278 | Sentence | denotes | She started symptoms on 2 April and entered the ICU on 5 April. Patient has a previous history of hypertension, diabetes mellitus, glaucoma and smoking habit. |
T95 | 279-339 | Sentence | denotes | She was admitted with frequent cough, wheezing and diarrhea. |
T96 | 340-420 | Sentence | denotes | The diagnosis of viral pneumonia by COVID-19 was confirmed by RT-PCR on 7 April. |
T97 | 421-539 | Sentence | denotes | Oxygen support at 5 l/min and treatment with ceftriaxone, lopinavir–ritonavir, chloroquine and IFN α-2b was indicated. |
T98 | 540-610 | Sentence | denotes | Chest images showed bilateral interstitial infiltration in both lungs. |
T99 | 611-716 | Sentence | denotes | Patient condition was classified as severe, although she did not require invasive mechanical ventilation. |
T100 | 717-798 | Sentence | denotes | A dose of itolizumab (200 mg) was given the day after her admission into the ICU. |
T101 | 799-1045 | Sentence | denotes | Two days after the antibody administration, together with the rest of the therapy, there was an improvement of the respiratory distress while the chest image showed a decrease of the alveolar interstitial infiltrate of both lungs (Figure 1C & D). |
T102 | 1046-1121 | Sentence | denotes | Patient left the ICU after a favorable clinical and radiological evolution. |
T103 | 1122-1198 | Sentence | denotes | IL-6 concentration was measured prior and after the antibody administration. |
T104 | 1199-1374 | Sentence | denotes | IL-6 level at baseline was lower than in previous cases (30 pg/ml), but also decreased 48 h and 168 h after itolizumab infusion, in parallel with patient recovery (Figure 2A). |
T105 | 1375-1457 | Sentence | denotes | IL-1 and TNF-α were untraceable before and 48 h after the antibody administration. |
T106 | 1458-1566 | Sentence | denotes | Regarding to AST concentration, the values were in the normal range during the treatment period (Figure 2B). |